A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus.
He J, Zheng P, Chen Y, Qi J, Ye C, Li D, Yang Y, Yang Y, Liu Q, Hu Y, Zheng X, Li W, Hua L, Yang Z, Chen H, Huang W, Sun W, Yang X, Long Q, Bai H, Ma Y.
He J, et al. Among authors: li d, li w.
Front Immunol. 2022 Sep 15;13:991857. doi: 10.3389/fimmu.2022.991857. eCollection 2022.
Front Immunol. 2022.
PMID: 36189310
Free PMC article.